Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
RICHMOND, Calif., April 25, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the first quarter 2017 after the close of trading on Tuesday, May 9, 2017. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
Investors interested in listening to the conference call may do so by dialing (877) 407-3036 for domestic callers or (201) 378-4919 for international callers, using Conference ID: 13581989. A live webcast of the event will be available on the “Investors” section of the company’s website at: www.eksobionics.com.
A replay of the call will be available for two weeks by dialing (877) 660-6853 for domestic callers or (201) 612-7415 for international callers and using Conference ID: 13581989. The webcast will also be available on the company’s website for one month following the completion of the call.
About Ekso Bionics®
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities. The company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO. For more information, visit: www.eksobionics.com.
Media Contact: Carrie Yamond / Rajni Dhanjani 212-867-1788 [email protected] Investor Contact: Debbie Kaster 415-937-5403 [email protected]
